Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow Imaging

Last updated: February 10, 2025
Sponsor: Rijnstate Hospital
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Carotid Artery Disease

Treatment

Conventional duplex

Ultrasound-based strain imaging

Ultrasound-based flow imaging

Clinical Study ID

NCT05270005
2021-1915
  • Ages > 18
  • All Genders

Study Summary

Rationale: Approximately 15-20% of strokes originates from an atherosclerotic plaque rupture in the carotid artery. To reduce the risk of stroke, patients should be evaluated for possible carotid endarterectomy (CEA), which is based on simple geometrical and clinical measures. Multiple studies have shown that the current risk stratification may lead to both over- and under-treatment for patients with carotid artery stenosis. This implicates that the current guidelines are lacking patient-specific parameters and have limited sensitivity. There is a wealth of evidence implicating the important role of local (disturbed) blood flow throughout the onset and progression of atherosclerosis. Novel flow-related measures, that go beyond simple geometrical indications, are required to improve diagnosis and treatment in patients with carotid artery stenosis. Nowadays, ultrasound (US) is one of the main techniques to assess for the presence and extent of carotid artery stenosis. However, current clinically-used US systems are unable to acquire and visualize the complex flow phenomena that play such a crucial role in the atherosclerotic disease process. With the advent of ultrafast ultrasound imaging, acquiring thousands of images per second, continuous tracking of flow in all directions became feasible, which enables us to image two-dimensional blood flow and possible disturbances with high accuracy and precision.

In this project, we aim to assess whether flow (related) parameters are associated with disease progression (and if so, which), in order to map the progression of atherosclerotic plaques using non-invasive, US-based blood flow imaging. In the future, this could improve risk stratification for individual patients for surgery, decrease patient mortality and morbidity, and therefore reduce healthcare costs.

Objective: To longitudinally assess the association between spatio-temporal blood flow velocities (peak systole and end-diastole at common carotid artery, maximum stenosis and internal carotid artery) and the progression of carotid atherosclerosis defined by duplex measurements.

Secondary objectives are to investigate the association between blood flow-derived parameters, including wall shear stress (WSS), vector complexity and vorticity, and the progression of atherosclerosis defined by duplex measurements. Furthermore, to assess the association between spatio-temporal blood flow velocities and blood flow-derived parameters (WSS, vector complexity and vorticity) and the progression of atherosclerosis as measured using ultrasound-based strain imaging.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult male or female (≥18 years old);

  • Informed consent form understood and signed, and patient agrees to follow-up visits;

  • Presence of carotid artery stenosis (between 30%-69%) according to conventionalduplex measurements (peak-systolic velocity of 125-230 cm/s [5] in combination withvisible lumen reduction >30% according to North American Symptomatic CarotidEndarterectomy Trial [NASCET] method);

  • Defined asymptomatic with respect to the ipsilateral carotid artery stenosis.

Exclusion

Exclusion Criteria:

  • A planned carotid revascularisation for the ipsilateral carotid artery stenosis atdate of inclusion;

  • History of carotid revascularisation at artery under investigation;

  • Visible near occlusion at asymptomatic stenosis side according to conventionalduplex measurements;

  • Life expectancy < 2 years;

  • Participating in another clinical study, interfering on outcomes

Study Design

Total Participants: 85
Treatment Group(s): 3
Primary Treatment: Conventional duplex
Phase:
Study Start date:
April 07, 2022
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • Rijnstate Hospital

    Arnhem,
    Netherlands

    Site Not Available

  • Radboud university medical center

    Nijmegen,
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.